Leadership
The success of Novartis Pharmaceuticals Corporation (NPC) is made possible by the members of our Pharma Executive Committee (PEC). Our Novartis Pharmaceuticals Corporation Pharma Executive Committee (PEC) consists of respected industry leaders and visionaries who share a common passion for innovation and excellence in execution.
Andy Wyss
Head of Pharma North American and President Novartis Pharmaceuticals Corporation
Read bio
Usman Azam, M.D.
Head, U.S. Medical & Drug Regulatory Affairs North America
Read bio
Steven Baert
Vice President Human Resources
Read bio
Ronald M. Califre
Vice President, Head of Research and Development, US Operations Global Head, Quality Assurance, Pharma Development
Read bio
Antonio Carvalho
Vice President and Head of US Pharmaceutical Operations
Read bio
Cynthia Cetani
Vice President and Chief Compliance Officer, Ethics & Compliance
Read bio
Nikos Georgiades
Executive Director and Head of Commercial Support Organization
Read bio
Brian Goff
Vice President and Head,Primary Care Business Unit
Read bio
Siddharth Kaul
Chief Financial Officer, North America
Read bio
Jesus Leal
Vice President and Head of Respiratory,
Infectious Diseases & Transplant Business Unit
Read bio
Carol Lynch
Vice President and Head of New Products and Business Development & Licensing
Read bio
Gregory Oakes
Vice President and Head, US Managed Markets and Market Access
Read bio
Marilyn Priestly
Vice President, Head of Diversity & Inclusion
Read bio
Lisa Pilla
Vice President and Head of Psychiatry/
Neuroscience Business Unit
Read bio
Kevin T. Rigby
Vice President, Public Affairs & Communications
Read bio
Dagmar Rosa-Bjorkeson
Vice President and Head of Multiple Sclerosis Business Unit
Read bio
Christi Shaw
Head Novartis Oncology, North American Region
Read bio
Dorothy Watson
Vice President and General Counsel
Read bio